Results 101 to 110 of about 124,217 (217)

Radiation therapy for persistent or progressive mediastinal lymphoma after chemotherapy in FeLV‐positive cats: a retrospective case series of four cats

open access: yesAustralian Veterinary Journal, EarlyView.
Background Mediastinal lymphoma in feline leukaemia virus (FeLV)‐positive cats is associated with a poor prognosis, and therapeutic options may be limited when adequate disease control is not achieved with chemotherapy. The efficacy of radiation therapy in this setting has not been established.
A Uno, T Hasegawa, T Mori
wiley   +1 more source

Long‐term follow‐up and post‐operative computed tomography surveillance following adrenalectomy in dogs

open access: yesAustralian Veterinary Journal, EarlyView.
Adrenal gland tumours in dogs have historically been associated with a guarded prognosis due to reported high perioperative mortality, recurrence and metastatic disease. More recent studies suggest improved outcomes following adrenalectomy. This retrospective study evaluated long‐term outcomes and postoperative computed tomography (CT) findings in dogs
TR Nash, GL Hosgood
wiley   +1 more source

Cilazapril-induced pleural effusion: A case report and review of the literature

open access: yesAnnals of Thoracic Medicine, 2010
We describe an unusual case of lymphocytic pleural effusion associated with the use of cilazapril, a novel angiotensin-converting-enzyme inhibitor (ACEI). An 80-year-old male was prescribed cilazapril for hypertension.
Kupeli Elif   +3 more
doaj  

Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but are associated with a growing spectrum of cardiovascular immune‐related adverse events. Among these, arrhythmias represent a rare yet potentially life‐threatening complication. ICI‐induced arrhythmias encompass a wide clinical spectrum, including atrial arrhythmias, conduction ...
Dong Wang   +4 more
wiley   +1 more source

Association of altered body composition with cardiac wasting in cancer with and without cardiotoxic therapy

open access: yesBritish Journal of Pharmacology, EarlyView.
Created in BioRender: Scientific Figure and Illustration Software. Background and Purpose In advanced cancer, associations among changes in body composition, cardiac wasting and prior cardiotoxic anticancer therapy have not been investigated. Experimental Approach Using bioelectrical impedance analysis (BIA), body composition was measured in 206 ...
Sara Hadzibegovic   +21 more
wiley   +1 more source

The Third PLeural Effusion And Symptom Evaluation (PLEASE-3) study: bendopnoea in patients with pleural effusion. [PDF]

open access: yesEur Respir J
Iacopetta BM   +9 more
europepmc   +1 more source

Ultrasonographic Features of Pleural Thickening in Cats With Pulmonary Carcinoma and Pleural Effusion: A Retrospective Descriptive Study [PDF]

open access: yesVet Med Sci
In cats with pulmonary carcinoma and pleural effusion, thoracic ultrasonography identified pleural thickening with variable morphology. In selected cats, thickened pleura or pleura‐associated lesions provided accessible targets for ultrasound‐guided sampling, supporting their potential role in diagnosis.
Toshima A, Fulkerson C, Murakami M.
europepmc   +2 more sources

Cord Blood‐Derived Fibroblast Activation Protein‐Targeted Chimeric Antigen Receptor Natural Killer Cells Persist in Vivo

open access: yesCancer Science, EarlyView.
We generated cord blood‐derived FAP‐targeted CAR NK cells and evaluated their activity against cancer‐associated fibroblasts. These cells showed antigen‐specific cytotoxicity in vitro and robust persistence in a pleural dissemination model, although in vivo anti‐CAF efficacy was limited, supporting further development of stromal‐targeted cellular ...
Takashi Hiroshima   +14 more
wiley   +1 more source

Phase II Study of Cisplatin/Gemcitabine Plus Necitumumab for Squamous NSCLC After ICI‐Platinum Therapy (WJOG14120L)

open access: yesCancer Science, EarlyView.
WJOG14120L NESSIE evaluated cisplatin, gemcitabine, and necitumumab (CGN) as second‐line therapy after ICI‐based treatment in 46 patients with advanced squamous NSCLC. ORR was 26.1%, DCR 87.0%, and median PFS 4.4 months. Although the predefined ORR threshold was not met, CGN showed modest antitumor activity with manageable toxicity.
Hiroshige Yoshioka   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy